<i>CHI3L1</i>, <i>NTRK2</i>, <i>1p/19q</i> and <i>IDH</i> Status Predicts Prognosis in Glioma
The aim of this study was to identify relevant biomarkers for the prognosis of glioma considering current molecular changes such as <i>IDH</i> mutation and 1p19q deletion. Gene expression profiling was performed using the TaqMan Low Density Array and hierarchical clustering using 96 sele...
Main Authors: | Elise Deluche, Barbara Bessette, Stephanie Durand, François Caire, Valérie Rigau, Sandrine Robert, Alain Chaunavel, Lionel Forestier, François Labrousse, Marie-Odile Jauberteau, Karine Durand, Fabrice Lalloué |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-04-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/11/4/544 |
Similar Items
-
<i>NTRK</i> Fusions in Sarcomas: Diagnostic Challenges and Clinical Aspects
by: Vasiliki Siozopoulou, et al.
Published: (2021-03-01) -
Energy Metabolism in <i>IDH1</i> Wild-Type and <i>IDH1</i>-Mutated Glioblastoma Stem Cells: A Novel Target for Therapy?
by: Cornelis J.F. van Noorden, et al.
Published: (2021-03-01) -
Cerebrospinal Fluid Penetration and Combination Therapy of Entrectinib for Disseminated <i>ROS1/NTRK</i>-Fusion Positive Pediatric High-Grade Glioma
by: Lisa Mayr, et al.
Published: (2020-12-01) -
Epigenetic Reprogramming for Targeting <i>IDH</i>-Mutant Malignant Gliomas
by: Jong-Whi Park, et al.
Published: (2019-10-01) -
mTORC2/Rac1 Pathway Predisposes Cancer Aggressiveness in <i>IDH1-</i>Mutated Glioma
by: Yang Liu, et al.
Published: (2020-03-01)